상세 보기
자료 필터
자료유형
발행연도
2008 ~ 2025
2008 2025
키워드
언어
전체 56건 중 11번부터 20번까지의 결과를 표시합니다.
2022
Article
Long-term follow-up results of cytarabine-containing chemotherapy for acute promyelocytic leukemia
- Young Hoon Park ;
- Dae-Young Kim ;
- Yeung-Chul Mun ;
- Eun Kyung Cho ;
- Jae Hoon Lee ;
- 외 32명
- 2022-07
- The Korean Journal of Internal Medicine
- 대한내과학회
Article
A Phase 1/2 Study of Lazertinib 240 mg in Patients With Advanced EGFR T790M-Positive NSCLC After Previous EGFR Tyrosine Kinase Inhibitors
- Cho, Byoung Chul ;
- Han, Ji-Youn ;
- Kim, Sang-We ;
- Lee, Ki Hyeong ;
- Cho, Eun Kyung ;
- 외 21명
- 2022-04
- Journal of Thoracic Oncology
- ELSEVIER SCIENCE INC
Article
Subsequent pregnancy and long-term safety after breast cancer: a retrospective analysis of Korean health insurance data
- Kang, Minsun ;
- Jung, Jaehun ;
- Chun, Yong Soon ;
- Park, Heung Kyu ;
- Cho, Eun Kyung ;
- ... Kim, Yunyeong
- 2022-02
- Annals of Surgical Treatment and Research
- 대한외과학회
Article
Efficacy and Safety of Trastuzumab Biosimilar (CT-P6) Compared With Reference Trastuzumab in Patients With HER2-positive Advanced Gastric Cancer A Retrospective Analysis
- Park, Joo-Hwan ;
- Yeo, Ja Hyun ;
- Kim, Young Saing ;
- Park, Inkeun ;
- Ahn, Hee Kyung ;
- ... Cho, Eun Kyung ;
- ... Yang, Jun-Young ;
- ... Lee, Woon Kee ;
- ... Sym, Sun Jin ;
- 외 2명
- 2022-02
- American Journal of Clinical Oncology
- LIPPINCOTT WILLIAMS & WILKINS
2021
Article
Cardiac Safety Assessment of Lazertinib: Findings From Patients With EGFR Mutation-Positive Advanced NSCLC and Preclinical Studies
- Jang, Seong Bok ;
- Kim, Kyeong Bae ;
- Sim, Sujin ;
- Cho, Byoung Chul ;
- Ahn, Myung-Ju ;
- ... Cho, Eun Kyung ;
- 외 6명
- 2021-10
- JTO Clinical and Research Reports
- Elsevier Inc.
Article
An open-label expanded access program of afatinib in EGFR tyrosine kinase inhibitor-naive patients with locally advanced or metastatic non-small cell lung cancer harboring EGFR mutations
- Park, Keunchil ;
- Kim, Jin-Soo ;
- Kim, Joo-Hang ;
- Kim, Young-Chul ;
- Kim, Hoon-Gu ;
- ... Cho, Eun Kyung ;
- 외 4명
- 2021-07-12
- BMC Cancer
- BMC
Article
Amivantamab in combination with lazertinib for the treatment of osimertinib-relapsed, chemotherapy-naive EGFR mutant (EGFRm) non-small cell lung cancer (NSCLC) and potential biomarkers for response.
- Bauml, Joshua ;
- Cho, Byoung Chul ;
- Park, Keunchil ;
- Lee, Ki Hyeong ;
- Cho, Eun Kyung ;
- 외 15명
- 2021-05
- Journal of Clinical Oncology
- LIPPINCOTT WILLIAMS & WILKINS
Article
Cardiac Safety Assessment of Lazertinib in Patients with EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer
- Haddish-Berhane, N. ;
- Cho, B. C. ;
- Ahn, M. ;
- Han, J. ;
- Kim, S. ;
- ... Cho, E. K. ;
- 외 12명
- 2021-03
- Journal of Thoracic Oncology
- ELSEVIER SCIENCE INC
Article
Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial
- Goldman, J.W. ;
- Dvorkin, M. ;
- Chen, Y. ;
- Reinmuth, N. ;
- Hotta, K. ;
- ... Cho, E.K. ;
- 외 234명
- 2021-01
- The Lancet Oncology
- ELSEVIER SCIENCE INC
2020
Article
Real World Experience of Nivolumab in Non-Small Cell Lung Cancer in Korea
- 임선민 ;
- 김상위 ;
- 조병철 ;
- 강진형 ;
- 안명주 ;
- ... 조은경 ;
- 외 14명
- 2020-10
- Cancer Research and Treatment
- 대한암학회